Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

GenomOncology To Enable CompanionDxTM Clinical Cancer Panels

Published: Monday, February 10, 2014
Last Updated: Monday, February 10, 2014
Bookmark and Share
The GO Clinical WorkbenchTM is selected to launch a series of next generation sequencing (NGS)-based assays.

GenomOncology announced today that CompanionDxTM has selected the company’s GO Clinical WorkbenchTM to launch a series of next generation sequencing (NGS)-based assays related to cancer. CompanionDxTM will leverage GenomOncology’s GO Clinical Workbench to manage the entire workflow: from raw sequencing data through delivery of an actionable clinical report to the client.

CompanionDx™ is a provider of both personalized pharmacogenomics evaluations and cancer companion diagnostic testing. When used separately or in conjunction, these two types of tests give physicians the resources necessary to develop comprehensive patient treatment profiles, thereby creating more certainty in therapeutic decisions.

David Lasecki, President of CompanionDxTM, commented “As we develop new tests that leverage next generation sequencing, we require a solution that meets our current needs but is scalable over time. GenomOncology’s platform and services will allow us to efficiently add new cancer panels and expand our testing options to best serve our clients.”

The GO Clinical Workbench provides the laboratory with a fully traceable analysis workflow and rules-based decision support tool for the clinical interpretation of somatic mutations.  

“Providing the oncologist with actionable data that is specific to a patient’s tumor in days instead of weeks adds to the medical utility of next generation sequencing,” added Manuel Glynias, President and CEO of GenomOncology. “The convergence of discovery, technology, and therapeutic development has created an unparalleled opportunity to improve clinical outcomes for many patients with cancer.”



Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GenomOncology to Present at Cleveland Clinic Medical Innovation Summit
Manuel Glynias will present at the Summit on Wednesday October 29 at the Cleveland Convention Center in Room 26.
Saturday, October 25, 2014
GenomOncology Collaborates with Roswell Park Cancer Institute
Collaboration on informatics solution for next-generation sequencing.
Wednesday, February 12, 2014
TriStar Technology Ventures Invests in GenomOncology
Chief Information Officer of MedCare joins board.
Thursday, February 06, 2014
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
TOPLESS Plants Provide Clues to Human Molecular Interactions
Scientists at Van Andel Research Institute have revealed an important molecular mechanism in plants that has significant similarities to certain signaling mechanisms in humans, which are closely linked to early embryonic development and to diseases such as cancer.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Find U.S. Breast Milk is Glyphosate Free
Washington State University scientists have found that glyphosate, the main ingredient in the herbicide Roundup, does not accumulate in mother’s breast milk.
Peering into the Vapors
Research suggests that e-cigarettes are much less harmful than previous studies have indicated.
New Technique for Mining Health-conferring Soy Compounds
A new procedure devised by U.S. Department of Agriculture (USDA) scientists to extract lunasin from soybean seeds could expedite further studies of this peptide for its cancer-fighting potential and other health benefits.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!